NDATOPICALCREAM
Approved
Mar 2010
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
8
Mechanism of Action
Interferon Inducers
Clinical Trials (5)
Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma
Started Oct 2025
18 enrolled
Cutaneous Basal Cell Carcinoma
Effectiveness of Imiquimod Topical Cream in Early Stage Cutaneous T-cell Lymphoma
Started Apr 2020
0Mycosis Fungoides
Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix
Started Feb 2015
22 enrolled
Cervical Intraepithelial Neoplasia
Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream
Started Jan 2013
21 enrolled
Actinic Keratosis
Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis
Started Sep 2012
589 enrolled
Actinic Keratosis
Loss of Exclusivity
LOE Date
Apr 30, 2030
50 months away
Patent Expiry
Apr 30, 2030